This study highlights the importance of addressing emotional regulation jointly with attachment to deepen the comprehension of the relational processes implicated in adaptation to breast cancer. Results supported a mediational hypothesis, presenting emotional regulation processes as relevant dimensions for the understanding of attachment associations with adaptation to breast cancer.
The glass-eel stage of the life history of Anguillid eels (Anguilla spp.) makes the important physiological transition from seawater (SW) to freshwater (FW) osmoregulation. Central to successful adaptation to fresh water is the switch from active hypoosmoregulation (ion excretion) to active hyperosmoregulation (ion uptake) to counter passive fluxes imposed by concentration gradients. Anguilla anguilla (L.) glass eels, captured from the lower Minho River estuary and maintained in brackish water (BW; 24), were fully capable of adapting to FW following acute transfer. In a comparison between SW- (34) and FW-adapted glass eels, gill Na+/K+-ATPase and Na+:K+:2Cl cotransporter (NKCC) expression were both markedly reduced in the FW group. Branchial mitochondria-rich chloride cells (MRCs) were also significantly larger in SW-adapted glass eels. Apical CFTR Cl channel immunoreactivity associated with branchial MRCs was also only present in SW-adapted glass eels. The expression of these three ion-transport proteins is strongly associated with active ion excretion in SW teleost fishes. In FW-adapted glass eels, cortisol treatment increased branchial Na+/K+-ATPase expression but was without effect on NKCC expression. Glucocorticoid receptor blockade by RU-486 had no effect on Na+/K+-ATPase or NKCC expression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.